Anti-HRASLS5 monoclonal antibody

Pre-made anti-HRASLS5 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to HRASLS5/HRASLS5 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2541-Ab-1/ GM-Tg-hg-IP2541-Ab-2Anti-Human HRASLS5 monoclonal antibodyHuman
GM-Tg-rg-IP2541-Ab-1/ GM-Tg-rg-IP2541-Ab-2Anti-Rat HRASLS5 monoclonal antibodyRat
GM-Tg-mg-IP2541-Ab-1/ GM-Tg-mg-IP2541-Ab-2Anti-Mouse HRASLS5 monoclonal antibodyMouse
GM-Tg-cynog-IP2541-Ab-1/ GM-Tg-cynog-IP2541-Ab-2Anti-Cynomolgus/ Rhesus macaque HRASLS5 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2541-Ab-1/ GM-Tg-felg-IP2541-Ab-2Anti-Feline HRASLS5 monoclonal antibodyFeline
GM-Tg-cang-IP2541-Ab-1/ GM-Tg-cang-IP2541-Ab-2Anti-Canine HRASLS5 monoclonal antibodyCanine
GM-Tg-bovg-IP2541-Ab-1/ GM-Tg-bovg-IP2541-Ab-2Anti-Bovine HRASLS5 monoclonal antibodyBovine
GM-Tg-equg-IP2541-Ab-1/ GM-Tg-equg-IP2541-Ab-2Anti-Equine HRASLS5 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2541-Ab-1/ GM-Tg-hg-IP2541-Ab-2; GM-Tg-rg-IP2541-Ab-1/ GM-Tg-rg-IP2541-Ab-2;
GM-Tg-mg-IP2541-Ab-1/ GM-Tg-mg-IP2541-Ab-2; GM-Tg-cynog-IP2541-Ab-1/ GM-Tg-cynog-IP2541-Ab-2;
GM-Tg-felg-IP2541-Ab-1/ GM-Tg-felg-IP2541-Ab-2; GM-Tg-cang-IP2541-Ab-1/ GM-Tg-cang-IP2541-Ab-2;
GM-Tg-bovg-IP2541-Ab-1/ GM-Tg-bovg-IP2541-Ab-2; GM-Tg-equg-IP2541-Ab-1/ GM-Tg-equg-IP2541-Ab-2
Products NameAnti-HRASLS5 monoclonal antibody
Formatmab
Target NameHRASLS5
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-HRASLS5 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2541-Ag-1Recombinant multi-species PLAT5/ HRASLS5/ HRLP5 protein


    Target information

    Target IDGM-IP2541
    Target NameHRASLS5
    Gene ID117245,66727,293711,718317,476046,101089718,522630
    Gene Symbol and Synonyms1700055A14Rik,1700086E08Rik,4921526K24Rik,HRASLS5,HRLP5,HRSL5,iNAT,PLAAT-5,PLAAT5,RGD1308376,RLP-1,RLP1
    Uniprot AccessionQ96KN8,Q4KLN5
    Uniprot Entry NamePLAT5_HUMAN,PLAT5_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000168004
    Target ClassificationN/A

    The target: HRASLS5, gene name: HRASLS5, also named as HRLP5, HRSL5, RLP1, iNAT. Enables N-acyltransferase activity; phospholipase A1 activity; and phospholipase A2 activity. Acts upstream of or within N-acylphosphatidylethanolamine metabolic process. Predicted to be located in cytosol. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.